Last reviewed · How we verify
NCT05496413
Investigating the Cognitive Source of Visual Working Memory Impairment in Schizophrenia
NA trial testing STARSTIM in Memory Deficits Schizophrenia Neurostimulator; Complications in 31 participants. Completed in 25 September 2023.
12 September 2023
Quick facts
| Lead sponsor | Taipei Medical University Shuang Ho Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 31 |
| Start date | 11 August 2022 |
| Primary completion | 12 September 2023 |
| Estimated completion | 25 September 2023 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- STARSTIM
Conditions studied
- Memory Deficits Schizophrenia Neurostimulator; Complications — all drugs for Memory Deficits Schizophrenia Neurostimulator; Complications →
Sponsor
Taipei Medical University Shuang Ho Hospital
Who can join
Adults 20 to 65, any sex, with Memory Deficits Schizophrenia Neurostimulator; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators plan to investigate the effect of enhancement on visual working memory (VWM) in patients of chronic schizophrenia and determine the predictive factors of effective treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Transcranial alternating current stimulation for neuropsychiatric disorders: a systematic review of treatment parameters and outcomes.
Gholamali Nezhad F, Martin J, Tassone VK, Swiderski A, et al · · 2024 · cited 7× · PMID 39211537 · DOI 10.3389/fpsyt.2024.1419243
Verify or expand the search:
- PubMed search for NCT05496413
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of STARSTIM
Trials testing the same drug.
- NCT03872310 — Cognitive Enhancement on Working Memory in Patients With Schizophrenia · NA · completed
Other Taipei Medical University Shuang Ho Hospital trials
Trials by the same sponsor.
- NCT07380685 — On-Demand AI Support Via LINE-Based GPT Assistant to Improve Emotional Resilience and Reduce Burnout Among Clinical Nurs · NA · not yet recruiting
- NCT07435714 — Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid · NA · not yet recruiting
- NCT07230366 — Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders · NA · not yet recruiting
- NCT07257393 — Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health · not yet recruiting
- NCT07192042 — Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizoph · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05496413 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University Shuang Ho Hospital
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05496413.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing